前立腺がんにおける割合に代わる腫瘍定量化の評価:ProQuantグループの原則
Andrew J Vickers1, Samson Fine2,
1Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
European urology
|December 19, 2025
Abstract:
We describe the rationale for using quantification of Gleason pattern 4 rather than the proportion of Gleason patterns for risk stratification in prostate cancer, as proposed by the ProQuant Group. We outline research that will be conducted to assess this strategy, and invite individuals interested in collaboration to join the group.


